Filing Details

Accession Number:
0001209191-23-011127
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-02-21 16:08:37
Reporting Period:
2022-07-05
Accepted Time:
2023-02-21 16:08:37
Original Submission Date:
2022-07-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660334 Verrica Pharmaceuticals Inc. VRCA Pharmaceutical Preparations (2834) 463137900
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741964 Ted White C/O Verrica Pharmaceuticals Inc.
44 West Gay Street, Suite 400
West Chester PA 19380
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-05 7,500 $2.10 29,466 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The original Form 4 inadvertently listed the incorrect number of shares purchased by the Reporting Person. This represents the correct number of shares.